Russell Investments Group
IMRX icon

Russell Investments Group’s Immuneering IMRX Stock Holding History

Russell Investments Group’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.4K Buy
+4,287
New +$21.7K ﹤0.01% 3802
2024
Q3 		– Sell
-6,594
Closed -$8.44K – 3740
2024
Q2 		$8.44K Buy
+6,594
New +$10.8K ﹤0.01% 3111

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Russell Investments Group's IMRX Position: Q2 2026 in Review

Russell Investments Group opened a new position in Immuneering (IMRX) in Q2 2026: 4,287 shares worth $21.4K. The stake represents ﹤0.01% of the portfolio and ranks #3802 among its holdings. This is a return to the name: Russell Investments Group previously reported a position in IMRX as recently as Q2 2024.

Russell Investments Group first reported a position in IMRX in Q2 2024 and has held it in 2 quarters since. 111 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • Russell Investments Group held 4,287 shares of Immuneering worth $21.4K as of Q2 2026.
  • Immuneering was a new Russell Investments Group position in Q2 2026.
  • Immuneering made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3802 holding.
  • Russell Investments Group first reported a position in Immuneering in Q2 2024 and has held it in 2 quarters since.
  • 111 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.